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ABSTRACT 
Objective:  To analyze the outcome of MVD as a first choice therapy when medical treatment has failed for the 
definitive management of Idiopathic Trigeminal Neuralgia. 
Material and Methods: 
Study was conducted at the Department of Neurosurgery PGMI / Lahore General Hospital, Lahore. This was a 
prospective observational case series from January 2007 to December 2008, 50 selected patients of Idiopathic 
Trigeminal Neuralgia diagnosed after radiological and clinical exclusion of secondary causes of Neuralgia 
presenting in whom medical management had failed were offered MVD as the first Intervention. All the patients 
were followed for one year post-operatively. 
Results:  Mean age was 59.2 years and minimum age 47 year and maximum 72 years. There was 16 males 
(32.0%) and females were 34 (68.0%). Male to female ratio was 1: 2.16. In 15 (30.0%) patients facial pain was 
on left side and 35 (70.0%) patients had right sided pain. V1 was found in 1 (2.0%) patient, V3 in 2 (4.0%) pati-
ents, V1 and V2 in 2 (4.0%) patients, V1-3 in 17 (34.0%) patients, V2,3 in 28 (56.0%) patients. An Arterial loop was 
found in 37 (74.0%) patients as the compressing agent and a Vein only in 4 (8.0%) patients. Mixed artery and 
vein in 8 (16.0%) patients. Thick arachnoid was the compressing agent in 1 (2.0%) patient. Out of 50 patients 46 
(92.0%) had Excellent outcome, 3 (6.0%) patients had Good outcome, 1 (2.0%) patient was in Fair outcome 
group. No patients were in Bad and Failure outcome groups. 
Conclusion:  Microvascular Decompression of trigeminal nerve is a safe and first choice therapy when medical 
treatment has failed for the definitive management of Idiopathic Trigeminal Neuralgia in otherwise medically fit 
patients provided Surgeon has adequate experience of performing the procedure. 
Key Words:  Idiopathic trigeminal neuralgia, Microvascular decompression, Fascial Pain. 
Abbreviations:  MVD = Microvascular Decompression, TGN = Trigeminal Neuralgia. 
 
INTRODUCTION 
Trigeminal neuralgia is a debilitating facial pain dis-
order. When medications fail, procedures including 
percutaneous glycerol rhizotomy, percutaneous radio-
frequency rhizotomy percutaneous balloon compres-
sion rhizolysis, stereotactic radiosurgical rhizolysis 
(GKS) i.e gamma knife surgery, and MVD are avai-
lable to the patient. Because the safety, efficacy, and 
durability of MVD for trigeminal neuralgia in the you-
ng and elderly patients have been established, many 
clinicians view MVD as the first line of treatment 
when medications fail.
1-8
 
 We present a case series of 50 selected cases of ty-
pical Idiopathic TGN definitively managed by micro-
vascular decompression of Trigeminal nerve after 
medical treatment has failed. 
 
MATERIALS AND METHODS 
From January 2007 to December 2008, 50 selected
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patients of Idiopathic Trigeminal Neuralgia presenting 
through outpatient department of L.G.H were admit-
ted. All the patients were diagnosed as “trigeminal 
neuralgia” with a typical pain on the basis of history 
and clinical examination, with a failed medical treat-
ment. All of these patients had been given previous 
medical therapy (carbamazepine or baclofen), to which 
they had become refractory or intolerant. MRI Brain 
was done to rule out any non-idiopathic cases. All the 
patients underwent microvascular decompression 
(MVD) of 5
th
 nerve in the Department of Neurosur-
gery Unit – I Lahore General Hospital Lahore. 
 Individual symptoms, clinical history, operative 
findings, and complications were recorded. 
 Operative results were assessed by clinical follow 
up and periodic phone surveys. The outcome of inter-
vention was graded by an independent reviewer other 
than the operating surgeon. 
 Out come was rated at the end of one year accord-
ing to following criteria, 
Excellent. (Immediate complete relief of pain with no 
complication) 
Good. (Complete relief of pain with in 3 month) 
Fair. (Good relief of pain with in 6 month no recur-
rence within 1 year) 
Bad. (Relief of pain is good but significant neurolo-
gical deficit beyond 3month) 
Failure. (No relief of pain at all.) 
 
Surgical Technique 
An MVD was performed under general anesthesia 
with the patient in the contralateral decubitus position 
A retromastoid incision was made behind the hairline, 
and a craniectomy about the asterion was performed. 
The intersection of the transverse sinus and sigmoid 
sinuses was identified, and the dura was opened. After 
appropriate brain relaxation was achieved with CSF 
drainage, the cerebellum was gently elevated and re-
tracted, and the trigeminal nerve was identified and 
examined for vascular contact at the root entry zone. 
Most compressive vessels were decompressed using 
shredded Sugicel pledgets, while some veins, if smal-
ler than the caliber of the superior cerebellar artery, 
were coagulated using bipolar cautery. Statistical ana-
lysis was performed with SPSS. 
 
RESULTS 
Age Incidence 
Peak age was observed at around 60 years of age. 
 Mean age was 59.2 years and minimum age 47 
year and maximum 72 years (Graph 1). 
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Graph 1: Age Incidence.  
 
Sex Incidence 
There were 16 males (32.0%) and 34 females (68.0%). 
Male to female ratio was 1: 2.16. 
 
Table 1:  Sex Incidence. 
 
Sex Number Percentage 
Male 16   32% 
Female 34   68% 
Total 50 100% 
 
Side Involved 
In 15 patients (30.0%) facial pain was on left side and 
35 patients (70.0%) had right sided pain. Right sided 
nerve compression was found to be nearly double than 
left (Table 2). 
 
Table 2:  Side Involved. 
 
Side Number Percentage 
Right Side 35   70% 
Left 15   30% 
Total 60 100% 
 
Division of Trigeminal Nerve Involved 
V1 was found in 1 patient (2.0%), V3 in 2 patients
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(4.0%), V1 and V2 in 2 (4.0%) patients, V1-3 in 17 
(34.0%) patients, V2,3 in 28 (56.0%) patients (Graph 
2). 
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Graph 2:  Division of TGN Involved. 
 
Table 3:  Division of TGN Involved. 
 
Division No. Percentage 
V1 1     2% 
V3 2     4% 
V1 and 2 2     4% 
V1-3 17   34% 
V2,3 28   56% 
Total 50 100% 
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Graph 3:  Operative Anatomical Findings. 
 
Compression of Root Entery Zone 
In a total of 50 patients undergoing MVD of Trigemi-
nal Nerve an Artery was found in 37 (74.0%) patients 
as the compressing agent and a Vein only in 4 (8.0%) 
patients, Mixed artery and vein in 8 (16.0%) patients. 
Thick arachnoid was the compressing agent in 1 pati-
ent i.e. patients (Graph 3 and Table 4). 
 
Table 4:  Operative Findings. 
 
Compressive Patients Number Percentage 
Artery 37   74% 
Vein   4     8% 
Mixed Artery and Vein   8   16% 
Thick Arachnoid 50 100% 
 
 At the end of one year Out of 50 Total 46 (92.0%) 
patients had Excellent outcome, 3 (6.0%) patients had 
Good outcome, 1 (2.0%) patient was in Fair outcome 
group. No patients were in Bad and Failure outcome 
groups (Table 5). 
 
Table 5:  Outcome. 
 
Outcome Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
 Excellent 46 92.0 92.0 92.0 
 Good   3 6.0 6.0 98.0 
 Fair   1 2.0 2.0 100.0 
 Total 50 100.0 100.0  
 
DISCUSSION 
The best known description of trigeminal neuralgia 
(TGN), or a similar condition, was written in the se-
cond century AD by Aretaeus of Cappadocia, a con-
temporary of Galen. Also known for his descriptions 
of migraine, he makes reference to a pain in which 
„spasm and distortion of the countenance take place‟.9 
Jujani, an 11th century Arab physician, mentions uni-
lateral facial pain causing spasms and anxiety in his 
writings. Interestingly, he suggests that the cause of 
the pain is „the proximity of the artery to the nerve‟.10 
 The first full account of TGN was published in 
1773 when John Fothergill presented a paper to the 
Medical Society of London. He described the typical 
features of the condition in detail, including paroxy-
sms of unilateral facial pain, evoked by eating or spea-
king or touch, starting and ending abruptly, and associ-
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ated with anxiety.
9
 Some time earlier, Nicolaus Andre 
Â had used the term „tic douloureux‟ to describe what 
he thought was a new clinical entity. However, it has 
been suggested, that no more than two of the patients 
he described in fact had TGN.
10
 
 While, drug therapy remains the first line of treat-
ment for trigeminal neuralgia (TGN), many patients do 
not achieve sufficient pain relief or suffer from side – 
effects. Furthermore, increasing numbers of patients 
are questioning the safety of long term medication. For 
these cases modern surgical treatments offer a safe and 
effective option with emphasis on microvascular deco-
mpression, a procedure which is reconstructive rather 
than destructive.
11
 
 The concept of microvascular decompression of 
the trigeminal nerve described by Dandy in 1934,
12
 re-
discovered by Gardner and Miklos,
13
 and fully recog-
nized and popularized by Jannetta
14
 was a milestone in 
the management of medically intractable trigeminal 
neuralgia. In the past 30 years thousands of patients 
have undergone successful microvascular decompress-
ion and today it represents one of the most widely used 
surgical options for trigeminal neuralgia. Several stu-
dies agree on high rate of long term success and even 
authors against the concept of microvascular compres-
sion perform it for its effectiveness.
15
 
 Some of the criticisms about MVD are based on 
presumed high mortality and morbidity. In our series 
there was no mortality and no permanent morbidity. At 
the end of one year Out of 50 Total patients 49(98.0%) 
patients were completely pain free and only 1 (2.0%) 
patient had Minor Trigeminal Complaints. Out of 50 
patients 46 (92.0%) had Excellent outcome, 3 (6.0%) 
patients had Good outcome, 1 (2.0%) patient was in 
Fair outcome group. No patients were in Bad and Fai-
lure outcome groups. Ataxia, disequilibrium, and gait 
disturbances sometimes found in the early postopera-
tive period. Fully recovered within 4 weeks without 
rehabilitation. Mean hospital discharge stay was 5 
days post-operatively. The clinical and patient charac-
teristics in our study were in line with the trends obser-
ved in other International and Pakistani studies.
12-18
 All 
our patients had failed medial treatment and were offe-
red MVD as the interventional treatment of choice and 
majority had per-operative evidence of a vessel on 5
th
 
nerve. 
 Prior to the late 1970s surgical approaches were 
not without risk or side – effects. The standard approa-
ches then were neuro-destructive, consisting of Gasse-
rian ganglion alcohol injection, percutaneous radio-
frequency thermocoagulation (RFL) and fractional 
section of the sensory root – now known as partial sen-
sory rhizotomy (PSR), carried out via a posterior fossa 
approach in the retro-mastoid region.
19
 By contrast, the 
early 1980s saw the introduction of non-destructive 
procedures; retrogasserian glycerol injection
20
 and 
microvascular decompression.
3
 Microvascular decom-
pression (MVD) has not only resulted in improved 
results but has led to a better understanding of the 
pathophysiology of Trigeminal Neuralgia. Importan-
tly, the non-destructive procedures do not usually cau-
se facial numbness. 
 MVD is now established as a safe and effective 
treatment for Trigeminal Neuralgia TGN in patients 
where medication has failed. Our study has indicated 
that MVD should be offered earlier and preferably as 
first – line treatment before any injection therapy whi-
ch can adversely affect the operative success rate. Par-
tial sensory rhizotomy still remains a good back-up 
procedure for those patients without vascular compres-
sion and gives a long – term cure rate similar to MVD. 
Meticulous surgical technique is essential and expe-
rience helps; it has been confirmed that surgeons per-
forming high numbers of MVD procedures achieve 
better results.
21
 
 In a recent study of literature for respective long-
term outcomes of various surgical modalities for trige-
minal neuralgia by Tatli et al
22
 the authors have con-
cluded that each surgical technique for treatment of tri-
geminal neuralgia has merits and limitations however, 
MVD provides the highest rate of long – term patient‟ 
satisfaction with the lowest rate of pain recurrence. 
 Stereotactic radiosurgery gamma knife surgery, 
might be considered an improvement of percutaneous 
and surgical techniques, but Pagni et al
23
 has reported 
in a recent study that contrary to the expectations, the 
rate of complete pain relief at long term is lower. Ga-
mma knife surgery and RFR (Radio Frequency Rhizo-
tomy) are less effective than MVD which, in spite of 
the risks it entails, remains the choice treatment for ty-
pical trigeminal neuralgia. 
 
CONCLUSION 
It is concluded from our study that Microvascular De-
compression is the first choice therapy when medical 
treatment has failed for the definitive management of 
Idiopathic Trigeminal Neuralgia in otherwise medi-
cally fit patients, provided Surgeon has adequate expe-
rience of performing the procedure. 
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